Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

United Health Products (UEEC) EPS (Weighted Average and Diluted) (2022 - 2025)

United Health Products (UEEC) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$0.0 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 35.96% to -$0.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$0.01, a 63.22% decrease, with the full-year FY2024 number at -$0.01, changed 0.0% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.0 for Q3 2025 at United Health Products, down from $0.02 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.02 in Q2 2025 to a low of -$0.01 in Q4 2024.
  • A 4-year average of -$0.0 and a median of -$0.0 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Biggest YoY gain for EPS (Weighted Average and Diluted) was 1300.21% in 2025; the steepest drop was 467.94% in 2025.
  • United Health Products' EPS (Weighted Average and Diluted) stood at -$0.0 in 2022, then grew by 9.48% to -$0.0 in 2023, then crashed by 465.99% to -$0.01 in 2024, then surged by 89.71% to -$0.0 in 2025.
  • Per Business Quant, the three most recent readings for UEEC's EPS (Weighted Average and Diluted) are -$0.0 (Q3 2025), $0.02 (Q2 2025), and -$0.01 (Q1 2025).